Primary nonresponse to anti-cd20 therapy in gastrointestinal posttransplant lymphoproliferative disorder.
Gökçe
Selim
S
Department of Pediatric Gastroenterology, Hepatology and Nutrition, Istanbul University Istanbul School of Medicine, Istanbul, Turkey.
Süoğlu
Ozlem Durmaz
OD
Sökücü
Semra
S
Gün
Feryal
F
Emiroğlu
Haldun
H
Celik
Alaaddin
A
Doğan
Oner
O
Cevikbaş
Uğur
U
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000276:immunology / Q000627:therapeutic use*; D002675:Child, Preschool; D017809:Fatal Outcome; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000209:etiology* / Q000276:immunology; D008297:Male; D012307:Risk Factors; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D000069283:Rituximab